Effect of Selenium on Triglyceride and Total Cholesterol, Weight Gain, and Physical Activity on Hemodialysis Patients: A Randomized Double‑Blinded Controlled Trial

Abdolamir Atapour, Sahar Vahdat, Mohsen Hosseini, Hamed Mohamadian


Background: End‑stage renal disease is one of the most important chronic diseases. Selenium is one of the so‑called rare elements which are essential for our body functions. Here, we aimed to investigate and the effects of selenium supplement therapy on weight gain, physical activity, and triglyceride (TG) and total cholesterol in patients under hemodialysis. Methods: The current study is a double‑blinded clinical trial performed on patients with ESRD under hemodialysis in 2019. In the beginning, serum selenium levels were assessed. All patients were randomly divided into two groups. The first group was under treatments with tablets of selenium 400 µg. Patients received selenium tablets three times after each hemodialysis session (3 times a week) and the other group received placebo tablets. 3 months after the beginning of the study, blood selenium levels, TG and total cholesterol, and weight and physical activities of patients were evaluated again and compared with the beginning. Results: A total of 78 patients were included. Serum selenium levels at the beginning of our study were 40.06 ± 8.50 in the intervention group and 45.00 ± 8.16 in control groups. Selenium levels and physical activities of patients were increased significantly in intervention group compared to baseline (P < 0.001 for both). Weight, physical activity, total cholesterol, and TG in both intervention and control groups did not change significantly after interventions (P > 0.05). Conclusions: We showed that selenium supplement therapies have beneficial effects in patients under hemodialysis. Furthermore, we showed that selenium supplement therapies have positive effects on serum selenium levels but no effects on total cholesterol and TG.


Lipid; physical activity; renal dialysis; selenium

Full Text:



Muzaale AD, Massie AB, Wang M‑C, Montgomery RA, McBride MA, Wainright JL, et al. Risk of end‑stage renal

disease following live kidney donation. JAMA 2014;311:579‑86.

Reutens AT, Atkins RC. Epidemiology of Diabetic Nephropathy.

Diabetes and the Kidney. 170: Karger Publishers; 2011. p. 1‑7.

Narres M, Claessen H, Droste S, Kvitkina T, Koch M,

Kuss O, et al. The incidence of end‑stage renal disease in the

diabetic (compared to the non‑diabetic) population: A systematic

review. PloS One 2016;11:e0147329.

Ghorbani NR, Qorbani M, Djalalinia S, Atoofi MK, Tajbakhsh R,

Mansourian M, et al. Oncogenic viral infections among Iranian

hemodialysis patients: A systematic review. Int J Prev Med


Himmelfarb J, Ikizler TA. Hemodialysis. N Engl J Med


Kianersi F, Taheri S, Fesharaki S, Fesharaki H,

Mirmohammadkhani M, Pourazizi M, et al. Ocular manifestations

in hemodialysis patients: Importance of ophthalmic examination

in prevention of ocular sequels. Int J Prev Med 2019;10:20.

Suri RS, Larive B, Sherer S, Eggers P, Gassman J, James SH,

et al. Risk of vascular access complications with frequent

hemodialysis. J Am Soc Nephrol 2013;24:498‑505.

Stolic R. Most important chronic complications of arteriovenous

fistulas for hemodialysis. Med Princ Practice 2013;22:220‑8.

Booth J, Pinney J, Davenport A. N‑terminal proBNP—marker

of cardiac dysfunction, fluid overload, or malnutrition in

hemodialysis patients? Clin J Am Soc Nephrol 2010;5:1036‑40.

Alharbi K, Enrione EB. Malnutrition is prevalent among

hemodialysis patients in Jeddah, Saudi Arabia. Saudi J Kidney

Diseases Transpl 2012;23:598‑608.

Ahmadi A, Mazooji N, Roozbeh J, Mazloom Z, Hasanzade J.

Effect of alpha‑lipoic acid and vitamin E supplementation on

oxidative stress, inflammation, and malnutrition in hemodialysis

patients. Iran J Kidney Dis 2013;7:461‑7.

Ekramzadeh M, Mazloom Z, Sagheb M. Association of

depression with selenium deficiency and nutritional markers

in the patients with end‑stage renal disease on hemodialysis.

J Renal Nutr 2015;25):381‑7.

Motedayen M, Sarokhani D, Ghiasi B, Khatony A, Dehkordi AH.

Prevalence of hypertension in renal diseases in Iran: Systematic

review and meta‑analysis. Int J Prev Med 2019;10:124.

Rayman MP. Selenium and human health. Lancet


Fairweather‑Tait SJ, Bao Y, Broadley MR, Collings R, Ford D,

Hesketh JE, et al. Selenium in human health and disease.

Antioxid Redox Signal 2011;14:1337‑83.

Branco V, Canário J, Lu J, Holmgren A, Carvalho C. Mercury

and selenium interaction in vivo: Effects on thioredoxin reductase

and glutathione peroxidase. Free Radic Biol Med 2012;52:781‑93.

Köhrle J. Selenium and the thyroid. Curr Opin Endocrinol

Diabetes Obes 2015;22:392‑401.

El‑Ramady H, Abdalla N, Fári M, Domokos‑Szabolcsy É.

Selenium enriched vegetables as biofortification alternative

for alleviating micronutrient malnutrition. Int J Hortic Sci


Stone CA, Kawai K, Kupka R, Fawzi WW. Role of selenium in

HIV infection. Nutr Rev 2010;68:671‑81.

Tonelli M, Wiebe N, Hemmelgarn B, Klarenbach S, Field C,

Manns B, et al. Trace elements in hemodialysis patients:

A systematic review and meta‑analysis. BMC Med 2009;7:25.

Bazeley J, Bieber B, Li Y, Morgenstern H, de Sequera P,

Combe C, et al. C‑reactive protein and prediction of 1‑year

mortality in prevalent hemodialysis patients. Clin J Am Soc

Nephrol 2011;6:2452‑61.

Kato A, Takita T, Furuhashi M, Maruyama Y, Hishida A.

Comparison of serum albumin, C‐reactive protein and carotid

atherosclerosis as predictors of 10‐year mortality in hemodialysis

patients. Hemodial Int 2010;14:226‑32.

Harsini SG, Habibiyan M, Moeini MM, Abdolmohammadi AR.

Effects of dietary selenium, vitamin E, and their combination

on growth, serum metabolites, and antioxidant defense system

in skeletal muscle of broilers under heat stress. Biol Trace Elem

Res 2012;148:322‑30.

Babak A, Rouzbahani R, Khalili Nejad R, Rafiee Zadeh A.

Comparison of Nutritional Behaviors and Physical Activities

between Overweight/Obese and Normal-Weight Adults. Adv

Biomed Res. 2019;8:62.

Amirkhanlou S, Emadi H, Eshghinia S. Evaluation of plasma

selenium level and its association with malnutrition in

hemodialysis patients in Golestan Province, Iran. J Clin Basic

Res 2017;1:17‑21.

Safaralizadeh R, Kardar G, Pourpak Z, Moin M, Zare A,

Teimourian S. Serum concentration of selenium in healthy

individuals living in Tehran. Nutr J 2005;4:32.

Buatois S, Miljkovic D, Manckoundia P, Gueguen R, Miget P,

Vançon G, et al. Five times sit to stand test is a predictor of

recurrent falls in healthy community‐living subjects aged 65 and

older. J Am Geriatr Soc 2008;56:1575‑7.

Bohannon RW. Reference values for the five‑repetition

sit‑to‑stand test: A descriptive meta‑analysis of data from elders.

Percept Mot Skills 2006;103:215‑22.

Koenig J, Fischer M, Bulant E, Tiran B, Elmadfa I, Druml W.

Antioxidant status in patients on chronic hemodialysis therapy:

Impact of parenteral selenium supplementation. Wiener Klinische

Wochenschrift 1997;109:13‑9.

Coombes JS, Fassett RG. Antioxidant therapy in hemodialysis

patients: A systematic review. Kidney Int 2012;81:233‑46.

Richard M, Arnaud J, Kuentz F, Foret M, Favier A. Zinc,

selenium and lipid peroxides levels in hemodialysed patients.

Free Radic Biol Med 1990;9:134.

Omrani H, Golmohamadi S, Pasdar Y, Jasemi K, Almasi A. Effect

of selenium supplementation on lipid profile in hemodialysis

patients. J Renal Inj Prev 2016;5:179.

Salehi M, Sohrabi Z, Ekramzadeh M, Fallahzadeh MK,

Ayatollahi M, Geramizadeh B, et al. Selenium supplementation

improves the nutritional status of hemodialysis patients:

A randomized, double‑blind, placebo‑controlled trial. Nephrology

Dialysis Transplantation. 2013;28:716‑23.

Kamińska‑Galwas B, Grzeszczak W, Jedryczko A,

Pachelski J. [Level of zinc, copper, selenium and nickel

in serum of patients treated for chronic renal failure with

hemodialysis‑‑influence of erythropoietin therapy]. Pol Arch

Med Wewn 1993;89:368‑76.

Stockler‑Pinto M, Mafra D, Farage N, Boaventura G,

Cozzolino S. Effect of Brazil nut supplementation on the blood

levels of selenium and glutathione peroxidase in hemodialysis

patients. Nutrition 2010;26:1065‑9.

Omrani HR, Rahimi M, Nikseresht K. The effect of selenium

supplementation on acute phase reactants and thyroid function

tests in hemodialysis patients. Nephrourol Mon 2015;7:e24781.